Gilead Sciences

Stoxx Europe 600 Index headed for its third week of gains

Expert WHO panel finds ‘no evidence’ that antiviral drug improves patient outcomes

European markets still post biggest weekly drop in a month

Significant blow to hopes of identifying existing medicines to treat disease

Acute shortages reported in number of countries because of difficulties with stocks from US

Experimental blend of drugs may suggest US president more ill than medical team admits

Doctor ‘extremely happy’, but source close to president strikes a more negative note

Iseq rises 0.48% on the day, with Ryanair and Aer Lingus owner IAG among travel gainers

Ryanair closes higher on news that British government is to ramp up Covid testing plans

Drugmaker more upbeat on full-year impact after sharp drop in medical visits early in the pandemic

Company to invest €7m as it also establishes paediatric centre of excellence here

EMA committee recommends drug’s use in adults and adolescents from 12 years of age

Markets report: Losses in technology and healthcare stocks halt a recent rally

The pan-European Stoxx 600 declined 0.8 per cent earlier, led lower by personal and household goods

Shares dip as it emerges there are no active talks on what would be politically sensitive deal

Investors back belief economic downturn from Covid-19 pandemic has bottomed out